Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07126171
A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever
Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd
Conditions
Chikungunya Fever
Interventions
Reduning injection The simulant of Reduning Injection
Updated 1 time since 2025 Last updated: Aug 10, 2025 Started: Aug 28, 2025 Primary completion: Nov 26, 2025 Completion: Feb 18, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Chikungunya Fever, this trial is actively recruiting participants. The trial is conducted by Jiangsu Kanion Pharmaceutical Co., Ltd and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jiangsu Kanion Pharmaceutical Co., Ltd
Data source: Jiangsu Kanion Pharmaceutical Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .